Related references
Note: Only part of the references are listed.Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder
Jan Gryczynski et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
What should clinicians do as fentanyl replaces heroin?
Adam Bisaga
ADDICTION (2019)
Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities
Ramin Mojtabai et al.
HEALTH AFFAIRS (2019)
Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment
Sandra D. Comer et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Rapid micro-induction of buprenorphine/naloxone for opioid use disorder in an inpatient setting: A case series
Sukhpreet Klaire et al.
AMERICAN JOURNAL ON ADDICTIONS (2019)
Fentanyl exposure among patients seeking opioid treatment
Taylor A. Ochalek et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2019)
Everything is not right anymore: Buprenorphine experiences in an era of illicit fentanyl
Sydney M. Silverstein et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2019)
Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method
Robert Hammig et al.
SUBSTANCE ABUSE AND REHABILITATION (2016)
Factors associated with complicated buprenorphine inductions
Susan D. Whitley et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2010)
Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument
D. Andrew Tompkins et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100 mg of daily methadone
James Rosado et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Buprenorphine: how to use it right
RE Johnson et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
The clinical opiate withdrawal scale (COWS)
DR Wesson et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2003)
Share Paper
